DK2501754T3 - Hidtil ukendt formulering af blandinger af fysiologisk chitosan-uorganisk salt-opløsning/blod til vævsreparation - Google Patents

Hidtil ukendt formulering af blandinger af fysiologisk chitosan-uorganisk salt-opløsning/blod til vævsreparation Download PDF

Info

Publication number
DK2501754T3
DK2501754T3 DK10831000.4T DK10831000T DK2501754T3 DK 2501754 T3 DK2501754 T3 DK 2501754T3 DK 10831000 T DK10831000 T DK 10831000T DK 2501754 T3 DK2501754 T3 DK 2501754T3
Authority
DK
Denmark
Prior art keywords
chitosan
blood
hcl
tissue
clots
Prior art date
Application number
DK10831000.4T
Other languages
English (en)
Inventor
Marc Lavertu
Anik Chevrier
Wei Ouyang
Michael D Buschmann
Caroline Hoemann
Original Assignee
Ortho Regenerative Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Regenerative Tech Inc filed Critical Ortho Regenerative Tech Inc
Application granted granted Critical
Publication of DK2501754T3 publication Critical patent/DK2501754T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/10—Heparin; Derivatives thereof

Claims (7)

1. Blod/chitosan-HCI-NaCI-sammensætning, omfattende: a) fuldblod; og b) en chitosanopløsning omfattende: chitosan med en gennemsnitlig molekylvægt på Mn < 232 kDa, HCI, og NaCI i en koncentration på 160 mM; hvor blod/chitosan-HCI-NaCI-sammensætningen har en pH-værdi på mellem 6,0 og 7,8; og hvor blod/chitosan-HCI-NaCI-sammensætningen koagulerer hurtigere end en blod/chitosan-HCI-3-glycerolphosphat-sammensætning.
2. Blod/chitosan-HCI-NaCI-sammensætning ifølge krav 1, hvor polymersammensætningen har en pH-værdi på mellem 6,2 og 6,7, og mere foretrukket en pH-værdi på 6,6.
3. Blod/chitosan-HCI-NaCI-sammensætning ifølge krav 1 eller 2, hvordeacety-leringsgraden (DDA) af chitosan er mellem 20 % til 100 %, og mere foretrukket mellem 76 % og 98 %.
4. Blod/chitosan-HCI-NaCI-sammensætning ifølge et hvilket som helst af kravene 1 til 3, hvor forholdet fuldblod:chitosan er 3:1 v/v.
5. Blod/chitosan-HCI-NaCI-sammensætning ifølge krav 1, hvor HCI er i en koncentration på 38 mM.
6. Blod/chitosan-HCI-NaCI-sammensætning ifølge et hvilket som helst af kravene 1 til 5, til anvendelse til reparation af væv hos et individ, hvor polymersammensætningen hæfter til vævet og fremmer celleproliferation.
7. Blod/chitosan-HCI-NaCI-sammensætning til anvendelse ifølge krav 6, hvor vævet er udvalgt fra gruppen bestående af brusk, menisk, ledbånd, sene, knogle, hud, hornhinde, periodontale væv, maxillofaciale væv, temporomandi-bular-væv, abscesser, resecerede tumorer og sår.
DK10831000.4T 2009-11-19 2010-11-18 Hidtil ukendt formulering af blandinger af fysiologisk chitosan-uorganisk salt-opløsning/blod til vævsreparation DK2501754T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26278609P 2009-11-19 2009-11-19
PCT/CA2010/001842 WO2011060544A1 (en) 2009-11-19 2010-11-18 Novel formulation of physiological chitosan-inorganic salt solution/blood mixtures for tissue repair

Publications (1)

Publication Number Publication Date
DK2501754T3 true DK2501754T3 (da) 2018-09-03

Family

ID=44059158

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10831000.4T DK2501754T3 (da) 2009-11-19 2010-11-18 Hidtil ukendt formulering af blandinger af fysiologisk chitosan-uorganisk salt-opløsning/blod til vævsreparation

Country Status (6)

Country Link
US (2) US20120321721A1 (da)
EP (1) EP2501754B1 (da)
CA (1) CA2814783A1 (da)
DK (1) DK2501754T3 (da)
ES (1) ES2688977T3 (da)
WO (1) WO2011060544A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2918452T3 (es) 2007-02-19 2022-07-15 Marine Polymer Tech Inc Composiciones hemostáticas y regímenes terapéuticos
CN103239762B (zh) * 2013-05-23 2014-09-17 中国海洋大学 一种甲壳素膜及其在眼科治疗中的应用
US11844874B2 (en) 2014-02-20 2023-12-19 Ortho Regenerative Technologies Inc. Lyophilized polymer scaffold compositions, processes for preparation and use in anabolic wound repair
FR3038838B1 (fr) 2015-07-13 2017-08-18 Synolyne Pharma Chitosane pour melange avec un fluide coagulable
CN109481726A (zh) * 2018-11-26 2019-03-19 广州新诚生物科技有限公司 一种可生物降解的止血骨蜡及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3623414B2 (ja) * 1999-11-05 2005-02-23 ニッピコラーゲン工業株式会社 ソーセージ用ケーシングおよびその製造方法
US6716970B2 (en) * 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
JP5089006B2 (ja) * 2000-06-29 2012-12-05 ピラマル ヘルスケア （カナダ） リミテッド 軟骨および他の組織の修復および再生のための組成物および方法
US20060159663A1 (en) 2004-07-30 2006-07-20 Lu Helen H Growth factor encapsulation system for enhancing bone formation
US20060251628A1 (en) * 2005-05-06 2006-11-09 Mohamed Attawia Defatted, dewatered bone marrow

Also Published As

Publication number Publication date
US20170333477A1 (en) 2017-11-23
EP2501754A1 (en) 2012-09-26
ES2688977T3 (es) 2018-11-07
EP2501754B1 (en) 2018-08-08
WO2011060544A1 (en) 2011-05-26
US20120321721A1 (en) 2012-12-20
EP2501754A4 (en) 2013-08-07
CA2814783A1 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
US20170333477A1 (en) Novel formulation of physiological chitosan-inorganic salt solution/blood mixtures for tissue repair
CN103687631B (zh) 促凝血肽及其衍生物以及它们的用途
DK2501392T3 (da) Opløselige chitosanformuleringer kombineret med blodpladeberiget plasma (prp) til vævsreparation
Seon et al. Functional improvement of hemostatic dressing by addition of recombinant batroxobin
Gu et al. Polyphosphate-crosslinked collagen scaffolds for hemostasis and alveolar bone regeneration after tooth extraction
Phogat et al. Nanocellulose mediated injectable bio-nanocomposite hydrogel scaffold-microstructure and rheological properties
Wang et al. Enhanced physical and biological properties of chitosan scaffold by silk proteins cross-linking
ITMI20091171A1 (it) Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
KR102031178B1 (ko) 주입형 온도감응성 목재 기반 산화 나노 셀룰로오스를 포함한 유착 방지제
Xue et al. Synthesis of injectable shear‐thinning biomaterials of various compositions of gelatin and synthetic silicate nanoplatelet
US20240115760A1 (en) Lyophilized polymer scaffold compositions, processes for preparation and use in anabolic wound repair
KR101510494B1 (ko) 관절 질환 치료용 조성물
WO2011060545A1 (en) Specific blood:chitosan mixing ratios producing a viscous paste-like implant with good handling properties for tissue repair
US9370608B2 (en) Continuous matrix with osteoconductive particles dispersed therein, method of forming thereof, and method of regenerating bone therewith
Kai et al. Addition of sodium hyaluronate and the effect on performance of the injectable calcium phosphate cement
WO2011060554A1 (en) Presolidified composition and method for in situ delivery of broad molecular weight range of chitosan implants with or without therapeutics for regenerative medicine and cartilage repair applications
AU2015305426A1 (en) Bioresorbable tissue repair composition
Yang et al. Effect of Dehydrothermal Treatment on the Structure and Properties of a Collagen-Based Heterogeneous Bilayer Membrane
JP7191007B2 (ja) 線維軟骨組織損傷治療用組成物
CN101890183A (zh) 用于治疗骨折的高强度粘合剂
KR102008999B1 (ko) 생체물질의 유실방지를 위한 생체막
Zhang et al. Nanofibrous chitin/Andrias davidianus skin secretion bioactive sponges with tunable biodegradation rates for bleeding wounds treatment
Liu et al. Pregelatinized hydroxypropyl distarch phosphate reinforced calcium sulfate bone cement for bleeding bone treatment
Yu et al. A hemostatic sponge derived from chitosan and hydroxypropylmethylcellulose
CN116712604A (zh) 一种阴离子改性骨修复水凝胶及其制备方法和应用